Nob Hill Therapeutics Announces Strategic Advisory Board to Accelerate Growth
Albuquerque, NM (PRWEB) November 22, 2021 -- Nob Hill Therapeutics (NHT) is pleased to announce the members of its Strategic Advisory Board. Under the
Stay updated with breaking news from Vertice Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Albuquerque, NM (PRWEB) November 22, 2021 -- Nob Hill Therapeutics (NHT) is pleased to announce the members of its Strategic Advisory Board. Under the
News and commentary from the endocrinology world
/PRNewswire/ -- Vertice Pharma announces the results of a recent study demonstrating the bioequivalence of Thyquidity™, an oral liquid solution of...
A new research study titled ” US Autoimmune Hemolytic Anemia Drugs market” successfully shows the entire scenario as well as a comprehensive overview
MannKind Corp. touted increased sales for its flagship drug Afrezza during its fourth quarter earnings report on Thursday, while pointing out its new direction toward therapies for lung and endocrine diseases. During the quarter, MannKind pulled in $10.1 million in revenue for Afrezza, its inhalable insulin, a 30 percent increase compared to sales in the same quarter of 2019. The Westlake Village biotech company reported an adjusted net loss of $13.2 million (-6 cents a share). That’s narrower than the net loss of $14.3 million (-7 cents) in the same period a year earlier. Revenue was $18.4...